Gabapentin Capsule
Product Images NDC 50090-7674
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
Figure 3 (Image 03)
This text provides data on the proportion of responders (patients with a 50% or greater reduction in pain score) in controlled studies of postherpetic neuralgia (PHN) for two different treatment regimens. Study 1 shows 34% of responders for the placebo (PBO) group and 29% for the GBP 3600 group. Study 2 displays 32% for placebo, 30% for GBP 1800, and 29% for GBP 2400. The statistical significance is indicated by the p-values shown as conclusion markers.*
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
Label Image (Lbl500907674)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.